Hani Kushlaf

768 total citations
19 papers, 119 citations indexed

About

Hani Kushlaf is a scholar working on Neurology, Rheumatology and Physiology. According to data from OpenAlex, Hani Kushlaf has authored 19 papers receiving a total of 119 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Neurology, 6 papers in Rheumatology and 5 papers in Physiology. Recurrent topics in Hani Kushlaf's work include Glycogen Storage Diseases and Myoclonus (5 papers), Lysosomal Storage Disorders Research (5 papers) and Myasthenia Gravis and Thymoma (3 papers). Hani Kushlaf is often cited by papers focused on Glycogen Storage Diseases and Myoclonus (5 papers), Lysosomal Storage Disorders Research (5 papers) and Myasthenia Gravis and Thymoma (3 papers). Hani Kushlaf collaborates with scholars based in United States, Italy and United Kingdom. Hani Kushlaf's co-authors include Stefano Sandrone, Ik Jae Lee, Luca Padua, Fraser J. Leversedge, Logan Schneider, Sneha Mantri, Daniel L. Menkes, Giuseppe Granata, Harini Sarva and Kathryn Nevel and has published in prestigious journals such as Neurology, Muscle & Nerve and Cells.

In The Last Decade

Hani Kushlaf

19 papers receiving 116 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hani Kushlaf United States 7 35 23 18 16 15 19 119
Animesh Das India 9 82 2.3× 19 0.8× 17 0.9× 7 0.4× 20 1.3× 46 173
Oluwaseun A. Sobowale United Kingdom 6 61 1.7× 94 4.1× 17 0.9× 17 1.1× 19 1.3× 9 255
Vitalie Lisnic Moldova 8 233 6.7× 15 0.7× 43 2.4× 13 0.8× 9 0.6× 21 339
Nick Hall United Kingdom 6 39 1.1× 21 0.9× 16 0.9× 23 1.4× 20 1.3× 7 154
Jocelyn Zwicker Canada 7 51 1.5× 25 1.1× 8 0.4× 25 1.6× 5 0.3× 21 124
Luciana León Cejas Argentina 8 65 1.9× 8 0.3× 9 0.5× 7 0.4× 10 0.7× 24 114
Jason S. Hawley United States 8 124 3.5× 7 0.3× 35 1.9× 14 0.9× 12 0.8× 23 247
Serhat Güler Türkiye 9 31 0.9× 6 0.3× 17 0.9× 22 1.4× 10 0.7× 26 157
Susanne Maxwell United Kingdom 5 246 7.0× 18 0.8× 10 0.6× 30 1.9× 12 0.8× 11 312
Ann Van Remoortel Belgium 10 45 1.3× 9 0.4× 4 0.2× 24 1.5× 10 0.7× 15 274

Countries citing papers authored by Hani Kushlaf

Since Specialization
Citations

This map shows the geographic impact of Hani Kushlaf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hani Kushlaf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hani Kushlaf more than expected).

Fields of papers citing papers by Hani Kushlaf

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hani Kushlaf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hani Kushlaf. The network helps show where Hani Kushlaf may publish in the future.

Co-authorship network of co-authors of Hani Kushlaf

This figure shows the co-authorship network connecting the top 25 collaborators of Hani Kushlaf. A scholar is included among the top collaborators of Hani Kushlaf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hani Kushlaf. Hani Kushlaf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Kushlaf, Hani, et al.. (2025). Global variations in diagnostic methods and epidemiological estimates in Pompe disease: findings from a scoping review. Orphanet Journal of Rare Diseases. 20(1). 216–216. 1 indexed citations
2.
Kushlaf, Hani, Jordi Díaz‐Manera, Drago Bratkovic, et al.. (2025). Switching Enzyme Replacement Therapy for Late‐Onset Pompe Disease From Alglucosidase Alfa to Cipaglucosidase Alfa Plus Miglustat: Post Hoc Effect Size Analysis of PROPEL. Muscle & Nerve. 72(2). 230–239. 1 indexed citations
3.
Kishnani, Priya S., Barry J. Byrne, Kristl G. Claeys, et al.. (2024). Switching treatment to cipaglucosidase alfa plus miglustat positively affects patient-reported outcome measures in patients with late-onset Pompe disease. Journal of Patient-Reported Outcomes. 8(1). 132–132. 3 indexed citations
4.
Howard, James F., Tuan Vu, Renato Mantegazza, et al.. (2024). Efficacy of ravulizumab in patients with generalized myasthenia gravis by time from diagnosis: A post hoc subgroup analysis of the CHAMPION MG study. Muscle & Nerve. 69(5). 556–565. 5 indexed citations
5.
Claeys, Kristl G., Hani Kushlaf, Noemi Hummel, et al.. (2024). Minimal clinically important differences in six-minute walking distance in late-onset Pompe disease. Orphanet Journal of Rare Diseases. 19(1). 154–154. 5 indexed citations
6.
Mozaffar, Tahseen, Drago Bratkovic, Barry J. Byrne, et al.. (2024). Effect size analysis of cipaglucosidase alfa plus miglustat versus alglucosidase alfa in ERT-experienced adults with late-onset Pompe disease in PROPEL. Molecular Genetics and Metabolism. 141(2). 107971–107971. 1 indexed citations
7.
Roy, Bhaskar, Teresinha Evangelista, Gerald Pfeffer, et al.. (2023). Provisional practice recommendation for the management of myopathy in VCP‐associated multisystem proteinopathy. Annals of Clinical and Translational Neurology. 10(5). 686–695. 4 indexed citations
8.
Kushlaf, Hani, Zoya Zaeem, Zaeem A. Siddiqi, et al.. (2022). Patient preference for virtual versus in‐person visits in neuromuscular clinical practice. Muscle & Nerve. 66(2). 142–147. 5 indexed citations
9.
Kushlaf, Hani, et al.. (2021). Genetic Modifiers of Hereditary Neuromuscular Disorders and Cardiomyopathy. Cells. 10(2). 349–349. 4 indexed citations
10.
11.
Kushlaf, Hani, et al.. (2021). A rare overlap of statin-induced anti-3-hydroxy-3-methyl-glutaryl-coenzyme A necrotizing autoimmune myositis and dermatomyositis. Rheumatology Advances in Practice. 5(3). rkab064–rkab064. 1 indexed citations
12.
Kushlaf, Hani, et al.. (2020). Toxin-Induced Channelopathies, Neuromuscular Junction Disorders, and Myopathy. Neurologic Clinics. 38(4). 765–780. 1 indexed citations
13.
Sandrone, Stefano, Hani Kushlaf, Sneha Mantri, et al.. (2018). Neurologic and neuroscience education. Neurology. 92(4). 174–179. 21 indexed citations
14.
15.
Lee, Ik Jae & Hani Kushlaf. (2018). Needle electromyography practice patterns in patients taking novel oral anticoagulants: A survey‐based study. Muscle & Nerve. 58(2). 307–309. 6 indexed citations
16.
17.
Kushlaf, Hani. (2013). Emerging Toxic Neuropathies and Myopathies. Psychiatric Clinics of North America. 36(2). 209–218. 6 indexed citations
18.
Erra, Carmen, Giuseppe Granata, G. Liotta, et al.. (2013). Ultrasound diagnosis of bony nerve entrapment: Case series and literature review. Muscle & Nerve. 48(3). 445–450. 16 indexed citations
19.
Kushlaf, Hani. (2011). Emerging Toxic Neuropathies and Myopathies. Neurologic Clinics. 29(3). 679–687. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Animesh Das Breakdown of academic impact, for papers by Oluwaseun A. Sobowale Breakdown of academic impact, for papers by Vitalie Lisnic Breakdown of academic impact, for papers by Nick Hall Breakdown of academic impact, for papers by Jocelyn Zwicker Breakdown of academic impact, for papers by Luciana León Cejas Breakdown of academic impact, for papers by Jason S. Hawley Breakdown of academic impact, for papers by Serhat Güler Breakdown of academic impact, for papers by Susanne Maxwell Breakdown of academic impact, for papers by Ann Van Remoortel
Rankless by CCL
2026